Anti Cancer Medicines
Showing 49–62 of 62 results
-
TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use. Initial U.S. Approval: 2019
Read more -
TRODELVY (sacituzumab govitecan-hziy) for injection, for intravenous use
Read more -
TRUQAP (capivasertib) tablets
Read more -
TUKYSA (tucatinib) tablets, for oral use
Read more -
UNITUXIN (dinutuximab) injection, for intravenous use
Read more -
Valamor (Ribociclib) Tablets
Read more -
VEGZELMA (bevacizumab-adcd) injection
Read more -
VISTOGARD (uridine triacetate) oral granules
Read more -
VITRAKVI (larotrectinib) oral solution
Read more -
VORAXAZE (glucarpidase) For Injection, for intravenous use. Initial U.S. Approval: 2012
Read more -
VOTRIENT (pazopanib) tablets. Initial U.S. Approval: 2009
Read more -
WELIREG (belzutifan) tablets
Read more -
XALKORI (crizotinib) capsules
Read more -
ZEJULA (niraparib) capsules, for oral use. Initial U.S. Approval: 2017
Read more
